Last 7 days
2.5%
Last 30 days
-12.0%
Last 90 days
-0.2%
Trailing 12 Months
22.5%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 441.4B | 324.2B | -0.20% | -6.09% | 21.94 | 1.36 | 12.71% | 16.40% |
VEEV | 28.6B | 2.1B | 10.63% | -13.49% | 72.07 | 13.75 | 17.88% | -8.53% |
CERN | 27.9B | - | 0.98% | 20.75% | 47.36 | 4.81 | - | - |
MID-CAP | ||||||||
CHNG | 9.0B | 3.5B | 11.88% | 31.28% | -116.8 | 2.57 | 7.15% | -34.72% |
TDOC | 4.2B | 2.4B | 0.08% | -64.09% | -0.31 | 1.75 | 18.41% | -3085.58% |
OMCL | 2.6B | 1.3B | 2.68% | -54.69% | 464.82 | 2.03 | 14.48% | -92.74% |
SMALL-CAP | ||||||||
PHR | 1.7B | 262.3M | -11.99% | 22.50% | -9.2 | 6.47 | 33.16% | -131.28% |
MDRX | 1.4B | 837.2M | -9.94% | -42.05% | 23.52 | 1.7 | 3.88% | -92.18% |
NXGN | 1.1B | 625.9M | -3.12% | -16.74% | 50.13 | 1.84 | 6.21% | 3223.77% |
SLP | 892.6M | 53.5M | 14.82% | -13.81% | 83.4 | 16.7 | 10.94% | 3.61% |
HSTM | 828.7M | 266.8M | 6.53% | 36.04% | 68.54 | 3.11 | 3.94% | 106.86% |
CCRN | 810.3M | 2.8B | -16.25% | 3.00% | 4.3 | 0.29 | 67.39% | 42.77% |
HCAT | 644.9M | 276.2M | -18.51% | -55.34% | -4.69 | 2.33 | 14.18% | 10.32% |
OPRX | 267.2M | 63.1M | -19.22% | -61.20% | -25.47 | 4.23 | 9.93% | -1043.45% |
TRHC | 151.4M | 357.1M | -7.60% | -2.95% | -1.09 | 0.42 | 33.22% | -57.66% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 7.0% | 262,344,000 | 245,156,000 | 228,296,000 | 213,233,000 | 197,021,000 |
S&GA Expenses | 3.1% | 152,209,000 | 147,614,000 | 131,440,000 | 106,421,000 | 82,174,000 |
R&D Expenses | 9.7% | 83,341,000 | 75,945,000 | 64,846,000 | 52,265,000 | 41,125,000 |
EBITDA | -1.4% | -164,403,000 | -162,125,000 | -140,247,000 | - | - |
EBITDA Margin | 5.2% | -0.63 | -0.66 | -0.61 | - | - |
Earnings Before Taxes | -2.1% | -184,355,000 | -180,559,000 | -158,161,000 | -117,979,000 | -79,513,000 |
EBT Margin | 4.6% | -0.70 | -0.74 | -0.69 | - | - |
Interest Expenses | 30.3% | -856,000 | -1,228,000 | -1,229,000 | -1,084,000 | -1,123,000 |
Net Income | -2.1% | -184,576,000 | -180,752,000 | -158,429,000 | -118,161,000 | -79,806,000 |
Net Income Margin | 4.6% | -0.70 | -0.74 | -0.69 | - | - |
Free Cahsflow | 10.6% | -118,055,000 | -132,008,000 | -119,092,000 | - | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -6.7% | 397 | 426 | 459 | 494 | 529 |
Current Assets | -9.4% | 287 | 316 | 349 | 386 | 464 |
Cash Equivalents | -12.9% | 210 | 241 | 269 | 314 | 400 |
Goodwill | 0% | 34.00 | 34.00 | 34.00 | 34.00 | 8.00 |
Liabilities | -0.7% | 77.00 | 78.00 | 78.00 | 77.00 | 71.00 |
Current Liabilities | 1.1% | 73.00 | 72.00 | 71.00 | 68.00 | 65.00 |
Long Term Debt | -23.7% | 4.00 | 5.00 | 6.00 | 7.00 | 5.00 |
Shareholder's Equity | -8.1% | 320 | 348 | 381 | 417 | 458 |
Retained Earnings | -7.6% | -568 | -527 | -481 | -429 | -383 |
Additional Paid-In Capital | 1.7% | 912 | 896 | 881 | 861 | 849 |
Shares Outstanding | 0.5% | 53.00 | 52.00 | 52.00 | 51.00 | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 3.3% | -112 | -115 | -102 | -74.71 | -32.65 |
Share Based Compensation | 3.6% | 54.00 | 52.00 | 45.00 | 36.00 | 30.00 |
Cashflow From Investing | 11.4% | -60.27 | -68.05 | -65.35 | -65.23 | -38.54 |
Cashflow From Financing | -21.5% | -18.33 | -15.09 | -13.27 | 235 | 217 |
82.0%
81.0%
76.4%
Y-axis is the maximum loss one would have experienced if Phreesia was unfortunately bought at previous high price.
15.4%
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-23 | MetLife Investment Management, LLC | unchanged | - | 183,778 | 864,400 | 0.01% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -1.37 | 29,000 | 144,000 | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -85.16 | -2,921,480 | 678,524 | -% |
2023-02-24 | SRS Capital Advisors, Inc. | unchanged | - | 391 | 1,391 | -% |
2023-02-21 | MACQUARIE GROUP LTD | reduced | -32.61 | -350,000 | 1,918,000 | -% |
2023-02-15 | Jasper Ridge Partners, L.P. | unchanged | - | 143,803 | 674,803 | 0.04% |
2023-02-15 | LAZARD ASSET MANAGEMENT LLC | reduced | -43.43 | -3,437,000 | 8,771,000 | 0.01% |
2023-02-15 | JANE STREET GROUP, LLC | reduced | -6.43 | 55,951 | 352,951 | -% |
2023-02-15 | Capital Impact Advisors, LLC | added | 4.17 | 200,038 | 688,038 | 0.67% |
2023-02-15 | PFS INVESTMENTS INC. | new | - | 212,000 | 212,000 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | t. rowe price investment management, inc. | 5.1% | 2,676,879 | SC 13G | |
Feb 14, 2023 | price t rowe associates inc /md/ | 0.3% | 180,384 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | brown advisory inc | 5.8% | 3,068,782 | SC 13G | |
Feb 09, 2023 | vanguard group inc | 7.34% | 3,872,425 | SC 13G/A | |
Jan 25, 2023 | blackrock inc. | 8.7% | 4,564,585 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 15.2% | 7,797,879 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 07, 2022 | blackrock inc. | 11.7% | 6,010,340 | SC 13G/A | |
May 10, 2021 | price t rowe associates inc /md/ | 10.7% | 5,402,206 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 2.46 -92.38% | 3.60 -88.85% | 7.20 -77.70% | 11.86 -63.27% | 16.25 -49.67% |
Current Inflation | 2.38 -92.63% | 3.39 -89.50% | 6.50 -79.87% | 10.46 -67.61% | 14.19 -56.05% |
Very High Inflation | 2.27 -92.97% | 3.12 -90.34% | 5.66 -82.47% | 8.84 -72.62% | 11.81 -63.43% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 28, 2023 | 3 | Insider Trading | |
Mar 28, 2023 | 3 | Insider Trading | |
Mar 28, 2023 | 4 | Insider Trading | |
Mar 23, 2023 | 10-K | Annual Report | |
Mar 23, 2023 | 4/A | Insider Trading | |
Mar 23, 2023 | S-8 | Employee Benefits Plan | |
Mar 22, 2023 | 8-K | Current Report | |
Mar 22, 2023 | 8-K | Current Report | |
Mar 20, 2023 | 4 | Insider Trading | |
Feb 14, 2023 | SC 13G | Major Ownership Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-24 | Gandhi Balaji | acquired | - | - | 21,428 | chief financial officer |
2023-03-17 | Linetsky David | sold (taxes) | -605 | 33.65 | -18.00 | svp, life sciences |
2023-03-16 | Linetsky David | sold (taxes) | -6,683 | 34.81 | -192 | svp, life sciences |
2023-03-15 | Linetsky David | sold (taxes) | -879 | 33.84 | -26.00 | svp, life sciences |
2023-02-02 | Rasmussen Randy | sold | -190,600 | 40.00 | -4,765 | chief financial officer |
2023-02-02 | VanDuyn Amy Beth | sold | -12,000 | 40.00 | -300 | svp, human resources |
2023-02-02 | Linetsky David | sold | -449,989 | 39.549 | -11,378 | svp, life sciences |
2023-02-02 | Davidoff Michael J. | sold | -294,564 | 39.2073 | -7,513 | svp, payer business |
2023-01-31 | Davidoff Michael J. | sold | -124,082 | 38.0037 | -3,265 | svp, payer business |
2023-01-31 | Munson Gillian | acquired | 9,972 | 37.49 | 266 | - |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Jan. 31, 2023 | Jan. 31, 2022 | Jan. 31, 2021 | |
Revenue: | |||
Total revenue | $ 280,910 | $ 213,233 | $ 148,677 |
Expenses: | |||
Cost of revenue (excluding depreciation and amortization) | 58,944 | 42,669 | 23,461 |
Payment processing expense | 50,323 | 38,719 | 28,925 |
Sales and marketing | 151,263 | 106,421 | 42,972 |
Research and development | 91,244 | 52,265 | 22,622 |
General and administrative | 80,384 | 68,674 | 40,460 |
Depreciation | 17,988 | 14,985 | 9,770 |
Amortization | 7,316 | 6,317 | 6,138 |
Total expenses | 457,462 | 330,050 | 174,348 |
Operating loss | (176,552) | (116,817) | (25,671) |
Other (expense) income, net | (175) | (78) | 1 |
Interest income (expense), net | 1,064 | (1,084) | (1,573) |
Total other income (expense), net | 889 | (1,162) | (1,572) |
Loss before provision for income taxes | (175,663) | (117,979) | (27,243) |
Provision for income taxes | (483) | (182) | (49) |
Net loss | $ (176,146) | $ (118,161) | $ (27,292) |
Net loss per share attributable to common stockholders - basic (in dollars per share) | $ (3.36) | $ (2.37) | $ (0.69) |
Net loss per share attributable to common stockholders - diluted (in dollars per share) | $ (3.36) | $ (2.37) | $ (0.69) |
Weighted-average common shares outstanding - basic (in shares) | 52,440,067 | 49,888,436 | 39,519,640 |
Weighted-average common shares outstanding - diluted (in shares) | 52,440,067 | 49,888,436 | 39,519,640 |
Subscription and related services | |||
Revenue: | |||
Total revenue | $ 128,975 | $ 95,514 | $ 69,042 |
Payment processing fees | |||
Revenue: | |||
Total revenue | 78,368 | 65,201 | 49,900 |
Network solutions | |||
Revenue: | |||
Total revenue | $ 73,567 | $ 52,518 | $ 29,735 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Jan. 31, 2023 | Jan. 31, 2022 |
---|---|---|
Current: | ||
Cash and cash equivalents | $ 176,683 | $ 313,812 |
Settlement assets | 22,599 | 19,590 |
Accounts receivable, net of allowance for doubtful accounts of $1,053 and $863 as of January 31, 2023 and 2022, respectively | 51,394 | 40,262 |
Deferred contract acquisition costs | 1,056 | 1,642 |
Prepaid expenses and other current assets | 10,709 | 11,043 |
Total current assets | 262,441 | 386,349 |
Property and equipment, net of accumulated depreciation and amortization of $59,847 and $53,321 as of January 31, 2023 and 2022, respectively | 21,670 | 34,645 |
Capitalized internal-use software, net of accumulated amortization of $37,236 and $31,139 as of January 31, 2023 and 2022, respectively | 35,150 | 17,643 |
Operating lease right-of-use assets | 569 | 2,337 |
Deferred contract acquisition costs | 1,754 | 2,437 |
Intangible assets, net of accumulated amortization of $2,549 and $1,178 as of January 31, 2023 and 2022, respectively | 11,401 | 12,772 |
Deferred tax asset | 81 | 515 |
Goodwill | 33,736 | 33,621 |
Other assets | 3,255 | 4,157 |
Total Assets | 370,057 | 494,476 |
Current: | ||
Settlement obligations | 22,599 | 19,590 |
Current portion of finance lease liabilities and other debt | 5,172 | 5,821 |
Current portion of operating lease liabilities | 934 | 1,281 |
Accounts payable | 10,836 | 5,119 |
Accrued expenses | 21,810 | 20,128 |
Deferred revenue | 17,688 | 16,493 |
Total current liabilities | 79,039 | 68,432 |
Long-term finance lease liabilities and other debt | 2,725 | 7,423 |
Operating lease liabilities, non-current | 349 | 1,276 |
Long-term deferred revenue | 125 | 65 |
Total Liabilities | 82,238 | 77,196 |
Commitments and contingencies (Note 11) | ||
Stockholders’ Equity: | ||
Common stock, $0.01 par value—500,000,000 shares authorized as of both January 31, 2023 and 2022; 54,187,172 and 52,095,964 shares issued as of January 31, 2023 and 2022, respectively | 542 | 521 |
Additional paid-in capital | 926,957 | 860,657 |
Accumulated deficit | (606,084) | (429,938) |
Treasury stock, at cost, 971,236 and 301,003 shares as of January 31, 2023 and 2022, respectively | (33,596) | (13,960) |
Total Stockholders’ Equity | 287,819 | 417,280 |
Total Liabilities and Stockholders’ Equity | $ 370,057 | $ 494,476 |